Discovery science View all stories Macrocyclic peptides: the next wave of drug discovery MSD scientists say the “Goldilocks” chemical modality could lead to new ways to impact disease September 18, 2023 Taking on Zaire ebolavirus How science and innovation fuel our efforts to help combat a rare but potentially deadly disease September 11, 2023 Acting early in cancer detection Diagnosing cancer early, before it has spread, may potentially lead to better outcomes August 22, 2023 New podcast: Meet the dealmakers MSD’s business development and licensing team explain how they identify new opportunities to strengthen our robust R&D pipeline June 5, 2023 Safeguarding the environment through green chemistry When a manufacturing process doesn’t meet our standards, we build an award-winning, planet-friendly one June 1, 2023 In our commitment to R&D, the numbers speak for themselves We follow the science where we can make the greatest difference March 22, 2023 Women in science? Absolutely Strong career paths and cutting-edge science draw more women scientists -- like chemists and engineers -- to our small molecule process R&D team February 3, 2023 VIDEO: Here for Good – When passion and curiosity fuel innovation Hear how one of our scientists balances her work and family life to accelerate our groundbreaking research February 3, 2023 Celebrating the life of trailblazing cardiovascular researcher Dr. Arthur Patchett Over the course of his career with MSD, Dr. Patchett changed the treatment paradigm for cardiovascular disease January 11, 2023 Moving quickly to help support efforts to address the Ebola outbreak in Uganda See how our people are planning to produce investigational vaccine for an urgent global health need November 4, 2022 Celebrating the opening of our latest state-of-the-art facility The FLEx Center will help us continue to harness the power of leading-edge science with agility October 28, 2022 MSD recognized on Fortune’s 2022 Change the World list Recognition highlights our continued focus on expanding access October 25, 2022 How MSD is using 3D printing to create innovative solutions 3D technology is helping optimize workstreams, shorten turn-around times, reduce costs and drive innovation August 1, 2022 Proteins in space: taking our research to the final frontier MSD Research Laboratories scientist Paul Reichert works with the International Space Station to drive innovation June 29, 2022 Fighting cancer requires an open mind Dr. Eric H. Rubin, oncology early development, on investigating the next frontier of cancer research June 1, 2022 35 Years: The Mectizan® Donation Program The Mectizan Donation Program is the longest-running, disease-specific drug donation program of its kind May 25, 2022 The Vaccine Pioneers Scientists who made giant strides in the fight against viral diseases and vaccine history April 11, 2022 Vaccines: our history, our legacy MSD and its legacy companies have been working to discover and develop vaccines for more than a century March 17, 2022 Innovation is key to combating antimicrobial resistance in Asia-Pacific Investing in research and innovative solutions gives us the best chance to fight these ‘superbugs’ February 24, 2022 6 New Year's resolutions MSD scientists are making in 2022 Hear what goals some of our senior scientists are tackling this year January 19, 2022 Dean Li: Agility is 'about letting the data guide you' The president of MSD Research Laboratories discusses how managing priorities is a key to scientific success January 13, 2022 4 science innovators reveal their earliest inspirations These medical researchers and scientists had a spark as children to invent and explore January 12, 2022 Innovation in the fast lane MSD and Corning are two years into a joint effort to maximize data science, one of today’s hottest research fields December 9, 2021 Colleagues ensure timely supply of our investigational oral antiviral COVID-19 medicine Get a behind-the-scenes look at Haarlem, Netherlands, where some of our first doses are being produced and packaged December 3, 2021 A Nobel Prize for a longtime MSD collaborator Princeton University’s David W.C. MacMillan is a co-winner of the 2021 Nobel Prize in chemistry November 10, 2021 Our commitment to HIV treatments and prevention through the years We continue to work at the forefront of the fight against HIV March 15, 2021 This scientist helps translate inventions into vaccines to protect public health Beth-Ann Coller, executive director, global clinical development, knows how disease outbreaks underscore the importance of vaccines February 25, 2021 Our new London Discovery Research Centre site The $1.32 billion, 220,000-square-foot research facility will be located in London’s “Knowledge Quarter” August 31, 2020
